Paper Details 
Original Abstract of the Article :
Oral administration of zolmitriptan, a novel 5-hydroxytriptamine receptor agonist, to eight healthy volunteers significantly reduced motor cortical excitability as tested by paired transcranial magnetic stimulation (TMS) at short interstimulus intervals. Zolmitriptan did not change motor thresholds ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1212/wnl.51.3.896

データ提供:米国国立医学図書館(NLM)

Zolmitriptan: A Serotonin Receptor Agonist with Effects on Motor Cortex

Migraines, debilitating headaches, can significantly impact an individual's quality of life. This study investigates the effects of zolmitriptan, a serotonin1B/1D receptor agonist, on motor cortical excitability in humans. The researchers employed paired transcranial magnetic stimulation (TMS) to assess motor cortical excitability before and after administering zolmitriptan to healthy volunteers. The results indicate that zolmitriptan significantly reduced motor cortical excitability, suggesting that its action may involve modulation of inhibitory processes within the motor cortex.

Zolmitriptan: A Multifaceted Approach to Migraine Relief

This study offers valuable insights into the mechanism of action of zolmitriptan, suggesting that its effects extend beyond simply relieving migraine symptoms. By demonstrating its influence on motor cortical excitability, the research provides a deeper understanding of the drug's potential benefits and potential implications for treatment strategies.

Migraines: A Journey Through the Labyrinth of Pain

Migraines can be like a desert sandstorm, a relentless assault on your senses that leaves you disoriented and overwhelmed. This study sheds light on the potential of zolmitriptan to manage migraine pain and explore the intricate pathways involved. Understanding the complex interplay of neurotransmitters and brain activity is crucial for developing effective treatments and empowering individuals to navigate this challenging journey.

Dr.Camel's Conclusion

This research sheds light on the effects of zolmitriptan, a serotonin receptor agonist, on motor cortical excitability in humans. The study's findings suggest that zolmitriptan's action may involve modulation of inhibitory processes within the motor cortex. This understanding could lead to a more comprehensive approach to managing migraine pain and improving patient outcomes.

Date :
  1. Date Completed 1998-10-20
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

9748054

DOI: Digital Object Identifier

10.1212/wnl.51.3.896

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.